DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

11145	Companies
245632	Keywords
173696	Articles
132572	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 09/30/2026 at 00:33, 7 days 23 hours ago

DBV Technologies files a license application for VIASKIN® Peanut

FDA Immunotherapy DBV Technologies Viaskin® Peanut BLA
BRIEF

published on 09/30/2026 at 00:33, 7 days 23 hours ago

DBV Technologies Submits Application for VIASKIN® Peanut Patch to U.S. FDA

Immunotherapy DBV Technologies FDA Application VIASKIN® Peanut Patch Children Allergy
PRESS RELEASE

published on 09/30/2026 at 00:28, 7 days 23 hours ago

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
DBV Technologies submits BLA to U.S. FDA for VIASKIN Peanut Patch in children aged 4-7 years, supported by successful Phase 3 VITESSE trial. Priority Review requested

DBV Technologies Viaskin Peanut Patch BLA VITESSE Trial Priority Review
BRIEF

published on 09/29/2026 at 14:38, 8 days 9 hours ago

JP Morgan Chase & Co. Reduces its Stake in DBV Technologies

Actions Participations Crossing Thresholds DBV Technologies JP Morgan
BRIEF

published on 09/25/2026 at 11:49, 12 days 12 hours ago

DBV Technologies: Threshold Crossing by JP Morgan Chase & Co.

Voting Rights Actions Crossing Thresholds DBV Technologies JP Morgan
BRIEF

published on 09/22/2026 at 10:45, 15 days 13 hours ago

JP Morgan exceeds 10% of DBV Technologies' capital

Threshold Crossing DBV Technologies JP Morgan Capital And Voting Rights Statement Of Intent
BRIEF

published on 09/04/2026 at 14:55, 1 month 3 days ago

DBV Technologies: Threshold Movements by JP Morgan Chase & Co.

Threshold Crossing DBV Technologies JP Morgan Chase Capital Participation Statement Of Intent
BRIEF

published on 09/03/2026 at 22:37, 1 month 4 days ago

DBV Technologies to Engage in September Investor Conferences

New York Investor Conferences Biopharmaceutical Fireside Chat DBV Technologies
BRIEF

published on 09/03/2026 at 22:37, 1 month 4 days ago

DBV Technologies is participating in investor conferences in September

New York Investor Conferences Investment Biopharmaceutical DBV Technologies
PRESS RELEASE

published on 09/03/2026 at 22:32, 1 month 4 days ago

DBV Technologies to Participate in Upcoming September Investor Conferences
DBV Technologies announces participation in upcoming investor conferences in September 2026, focusing on biopharmaceutical developments for food allergies and immunologic conditions

Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions

Accesswire

Published on 10/07/2026 at 23:30, 55 minutes ago

Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 2 hours 20 minutes ago

Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 7 hours 25 minutes ago

BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 8 hours 55 minutes ago

Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 9 hours 55 minutes ago

Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance

View all ACCESSWIRE

EQS Group

Published on 10/07/2026 at 23:30, 55 minutes ago

Acuity Analytics expands US data and technology capabilities with acquisition of Continuus
Published on 10/07/2026 at 23:20, 1 hour 5 minutes ago

BAR LEONE, HONG KONG, IS THE WORLD'S BEST BAR AS THE LIST OF THE 50 BEST BARS 2026 IS REVEALED
Published on 10/07/2026 at 22:00, 2 hours 25 minutes ago

Invitation - Q3 2026 Trading Update Conference Call
Published on 10/07/2026 at 21:35, 2 hours 50 minutes ago

OCI N.V. Notes Enterprise Chamber Decision Not to Order Inquiry
Published on 10/07/2026 at 20:55, 3 hours 30 minutes ago

innoscripta SE Initiates Independent External Investigations to Clarify the Facts Underlying the Authorities’ Investigations and Review Clusterix’s Documentation and Control Mechanisms

Les Echos

Published on 10/07/2026 at 18:19, 6 hours 5 minutes ago

Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:46, 6 hours 39 minutes ago

Press release 7 October 2026
Published on 10/07/2026 at 17:45, 6 hours 40 minutes ago

Availability of the Pre-Q3 2026 Sales Communication
Published on 10/07/2026 at 15:54, 8 hours 31 minutes ago

Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 08:15, 16 hours 10 minutes ago

EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS

View all LES ECHOS COMFI WIRE